Moreover, G9668 treatment led to significantly greater numbers of tumor-infiltrating cytotoxic CD8+ T cells (Fig. 5 E) and higher expression by these cells of the activation markers granzyme B, PD-1, and CD44 (Fig. 5 F). The gene discussed is GZMB; the disease is neoplasm.